CLS vs SANM: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
CLS is the larger of the two ($38.11B market cap): the incumbent the market prices for continued execution (16.70x forward earnings, beta 1.51). SANM is the smaller challenger ($9.95B), cheaper on forward earnings (13.33x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
CLS vs SANM: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | CLS | SANM | What it tells you |
|---|---|---|---|
| Market cap | $38.11B | $9.95B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 16.70 | 13.33 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 36.38 | 33.19 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 1.51 | 1.56 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 53% of range | 43% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 15.37 | 4.11 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: SANM is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how CLS and SANM affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CLS and SANM share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CLS and SANM exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Celestica (CLS) do?
Celestica is a Toronto-based electronics manufacturing services (EMS) and supply-chain company that designs, builds, and tests hardware for other companies. It reports in two segments. Connectivity & Cloud Solutions (CCS) is the larger and faster-growing one, serving data-center and communications customers with networking switches, servers, storage, and increasingly custom AI/ML compute hardware; in Q1 2026 CCS was about ~80% of total revenue and grew roughly ~76% year over year, with hyperscaler customers making up the majority of that segment. Advanced Technology Solutions (ATS) is the diversified segment covering aerospace and defense, industrial, HealthTech, and capital equipment. The company makes money on the volume and complexity of the hardware it manufactures and on higher-value design and joint-design-manufacturing (JDM) work, where margins are structurally better than commodity contract assembly.
What does Sanmina Corporation (SANM) do?
Sanmina Corporation, founded in Silicon Valley in 1980 and headquartered in San Jose, California, is a Fortune 500 global provider of integrated manufacturing solutions, components, and repair, logistics and after-market services. It serves original equipment manufacturers (OEMs) across industrial and energy, medical, defense and aerospace, automotive, communications networks, and cloud and AI infrastructure, running two businesses: Integrated Manufacturing Solutions and Components, Products and Services. It employs roughly 35,000 people and serves customers from around 20 countries.
CLS vs SANM: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- CLS drivers: Hyperscaler-driven CCS growth; AI networking and compute content.
- SANM drivers: AI and cloud infrastructure ramp; AMD partnership and preferred-manufacturer status.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. For SANM, sanmina operates on thin EMS margins (non-GAAP operating margin around 6%), so small execution errors or pricing pressure can meaningfully affect profits.
CLS or SANM: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CLS if you believe its drivers more; SANM if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CLS and SANM guides.
CLS vs SANM: the full fundamentals
CLS. These figures are tied to the June 2026 reporting picture and Celestica's Q1 2026 results announced in late April 2026. The company has repeatedly beaten and raised guidance on AI-driven demand, and its valuation multiple has expanded well above its historical EMS range to reflect those growth expectations. A premium multiple means the stock is more sensitive to any disappointment in growth or margins than a traditional contract manufacturer would be.
SANM. Revenue and earnings stepped up sharply after the ZT Systems acquisition closed in late 2025, roughly doubling quarterly sales. The stock trades at a large premium to its roughly 15x ten-year average P/E, reflecting AI-driven enthusiasm, so much of the future growth appears to be priced in.
Headline figures (approximate, June 2026): CLS shows q1 2026 revenue ~$4.05B (up ~53% YoY), ccs segment growth ~76% YoY in Q1 2026 (~80% of revenue), 2026 revenue guidance ~$19B (raised from ~$17B), adjusted operating margin ~8.0% Q1 2026; ~8.1% 2026 guide; SANM shows revenue (fy2026 guidance) ~$13.7B to $14.3B, q2 fy2026 revenue ~$4.0B (up ~102% YoY), fy2025 revenue ~$8.1B, non-gaap eps (fy2026 guidance) ~$10.75 to $11.35.
The bottom line: CLS vs SANM
CLS and SANM are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CLS and SANM exposure against your real portfolio. It is not an investment adviser.
Wondering how CLS or SANM fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Celestica with AI
Connect the broker you already use and ask Walnut's AI how CLS fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between CLS and SANM?
+
Celestica is a Toronto-based electronics manufacturing services (EMS) and supply-chain company that designs, builds, and tests hardware for other companies. Sanmina Corporation, founded in Silicon Valley in 1980 and headquartered in San Jose, California, is a Fortune 500 global provider of integrated manufacturing solutions, components, and repair, logistics and after-market services. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is CLS or SANM the better stock?
+
Neither is universally better. CLS is the larger incumbent; SANM is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, CLS or SANM?
+
On forward P/E (as of August 2026), CLS trades at 16.70x and SANM at 13.33x, so SANM is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both CLS and SANM?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of CLS vs SANM?
+
CLS: Customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. EMS has historically run thin margins, leaving limited cushion if pricing or volumes compress. The business is tied to AI capital spending, which is cyclical and could slow or pause after a heavy buildout phase. And the stock has re-rated to a much higher multiple than its EMS history, so it carries both competition from Jabil, Flex, Foxconn, and ODMs and the risk that high growth expectations are not met. SANM: Sanmina operates on thin EMS margins (non-GAAP operating margin around 6%), so small execution errors or pricing pressure can meaningfully affect profits. The ZT Systems business creates heavy revenue concentration tied to AI and data-center capital spending, which is cyclical and could slow if hyperscaler or AMD-related demand cools. Integration of a multi-billion-dollar acquisition carries operational and financial risk, and the AMD relationship makes results partly dependent on one large partner. The stock now trades at a large premium to its long-run average valuation, so disappointment relative to lofty AI expectations could pressure the shares. Broader risks include supply-chain disruption, customer concentration, and macro cyclicality across its industrial and communications markets.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CLS or SANM; figures are approximate and dated (as of August 2026). Verify current data before investing.